Evidence map›Paper›PMID 40591640›Full record

ArticlePloS one2025

Chiliadenus iphionoides: From chemical profiling to anticancer, antioxidant, α-amylase, and α-glycosidase activities.

Odey Bsharat, Yousef Salama, Nisreen Al-Hajj, Nawaf Al-Maharik

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Frontiers in medicine · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Odey BsharatDepartment of Chemistry, Faculty of Sciences, An-Najah National University, Nablus, Palestine.ORCID https://orcid.org/0000-0002-2375-0790
Yousef SalamaAn-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Nisreen Al-HajjDepartment of Chemistry, Faculty of Sciences, An-Najah National University, Nablus, Palestine.
Nawaf Al-MaharikDepartment of Chemistry, Faculty of Sciences, An-Najah National University, Nablus, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, essential oils (EOs) have garnered attention for their biological properties as a source of natural compounds with anticancer, antibacterial, and antioxidant effects. Chiliadenus iphionoides (Boiss.& Blanche) Brullo is a fragrant aromatic species indigenous to Palestine and the neighboring countries. It is utilized by the Bedouins for the treatment of many ailments. This study aimed to analyze the chemical composition of essential oil extracted from the desiccated leaves of Chiliadenus iphionoides (Boiss.& Blanche) Brullo and to assess its in vitro antioxidant, anticancer, and α-amylase and lipase inhibitory activities. The EO obtained during hydrodistillation was analyzed using gas chromatography-mass spectrometry to ascertain their chemical composition. GC-MS analysis of the EO from dried Chiliadenus iphionoides (Boiss.& Blanche) Brullo leaves identified 47 compounds, comprising 98.81% of the total oil. The predominant constituents included cresol methyl ether (52.93%), ethyl 2-octynoate (14.36%), epi-α-cadinol (6.56%), 1,8-cineole (4.25%), and 7-epi-α-eudesmol (3.66%). The EO exhibited significant antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) with an IC50 value of 19.83 ± 0.99 μg/mL. Nevertheless, it exhibited limited lipase activity and subpar α-amylase activity. Chiliadenus iphionoides (Boiss.& Blanche) Brullo EO exhibited significant cytotoxicity against B16F10 and MCF-7 cancer cell lines, with IC50 values of 8.74 ± 0.11 and 13.68 ± 0.17 μg/mL, respectively. The combination of the anticancer medication Taxol (10 ng) with Chiliadenus iphionoides (Boiss.& Blanche) Brullo EO at concentrations of 25 μg/mL and 50 μg/mL significantly enhanced the inhibitory efficacy of Taxol against MCF-7 and B16F10 cells.

Indexed as

alpha-AmylasesAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntioxidantsGlycoside HydrolasesOils, VolatileAnimalsCell Line, TumorGas Chromatography-Mass SpectrometryHumansLipaseMicePlant Leavesalpha-AmylasesAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntioxidantsGlycoside HydrolasesLipaseOils, Volatile

Identifiers

PMID40591640
PMCPMC12212542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.